• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CERENOVUS, INC. CEREGLIDE; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CERENOVUS, INC. CEREGLIDE; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number NIC71132U
Medical Device Problem Codes Crack (1135); Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/10/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, sex, gender, weight, race, and ethnicity were not provided.Section d.2b: procode is nry/qjp.Section h.3: the device is available to be returned for evaluation and testing.However, it has not been received to date.If the device returns, a device investigation will be performed.A review of manufacturing documentation associated with this lot (31303031) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no internal actions related to device manufacture or inspection.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by johnson & johnson medtech, or its employees that the report constitutes an admission that the product, johnson & johnson medtech, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event or Problem Description
The healthcare professional reported that during a procedure, ¿we had two cereglide catheters where the hubs were cracked ¿ drawing air.¿ the two 132cm cereglide 71 intermediate catheter (nic71132u) were from two different lots: the first cereglide is from lot 31303031 and the second cereglide is from lot 31411523.There was no report of any patient impact.
 
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to include the additional event information received on 14-jan-2025.[additional information]: on 14-jan-2025, additional information was received.The information indicated that the patient is a 68-year-old female.The procedure was a thrombectomy targeting the middle cerebral artery (mca).The two cereglide catheters were used during the same procedure.The replacement was another cereglide catheter.The information confirmed the procedure was successfully completed with the new replacement cereglide.There was no negative patient impact and no delay in the procedure from the reported issue.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to report that the product analysis lab received the complaint device on 28-jan-2025.A supplemental 3500a report will be submitted once the product investigation has been completed.Updated sections: b.4, d.9, g.3, g.6.H.2, h.3, h.6, and h.11.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4) the purpose of this mdr submission is to report the investigational finding of the returned device.The complaint product was returned and received for evaluation and analysis.The investigation is documented below.Investigation summary: a non-sterile 132cm cereglide 71 intermediate catheter was received contained in the decontamination pouch.Visual inspection was performed.No appearance of damages was observed.The returned cereglide intermediate catheter was flushed using a lab sample syringe with water.Water leak was observed at the hub section.Microscopic inspection was performed.Under magnification, it was noted that the hub appeared to have been subjected to force, which caused the outer plastic layer to fracture, slightly exposing the internal wires.However, the device remained in one piece connected by the internal braided wires.The issue reported that the device was cracked and drawing air were confirmed during the inspection.According to risk documentation hub damage during attachment of hemostasis valve is a potential failure mode that can result from the handling of hemostasis valve and hub, where excessive force could have been applied, leading to damage to the device.Devices undergo 100% inspection for exposed wire inside the hub during hub injection molding process, and 100% inspection for catheter kinks or damages during catheter loading into hoop.Thus, it is not likely that the device left the facility in a damaged condition; intra-operative factors may have contributed to the issue reported, however, with the amount of information available, a root cause cannot be established.A review of manufacturing documentation associated with this lot (31303031) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no internal actions related to device manufacture or inspection.As part of johnson & johnson medtech quality process, all devices are manufactured, inspected, and released to approved specifications.Although no conclusion could be reached as to the cause of the event reported, the instructions for use (ifu) contains the following precautions: before removing the intermediate catheter from the packaging hoop dispenser, rotate the luer on the packaging hoop 90 degrees.Gently remove the catheter and accessories from the hoop and inspect prior to use to verify that they are undamaged.Caution: do not use a catheter that has been damaged in any way.If damage is detected, replace with another catheter that is not damaged.Do not advance or withdraw an intravascular device against resistance until the cause of the resistance is determined by fluoroscopy.Movement of the device against resistance could damage the device or cause patient injury.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.Updated sections: b.4, g.3, g.6.H.2, h.3, h.6, and h.11.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CEREGLIDE
Common Device Name
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
CERENOVUS, INC.
6303 waterford district drive
suites 215 & 315
miami FL 33126
Manufacturer (Section G)
CERENOVUS INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvarcar
juarez chihuahua 32574
MX   32574
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
303552-6892
MDR Report Key21020001
Report Number3007628272-2024-00071
Device Sequence Number11792352
Product Code NRY
UDI-Device Identifier10886704085409
UDI-Public(01)10886704085409(11)240405(17)270331(10)31303031
Combination Product (Y/N)N
Initial Reporter StateSD
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 02/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberNIC71132U
Device Lot Number31303031
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/11/2024
Supplement Date Received by Manufacturer01/14/2025
01/28/2025
02/07/2025
Initial Report FDA Received Date12/26/2024
Supplement Report FDA Received Date01/14/2025
01/28/2025
02/07/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/05/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age68 YR
Patient SexFemale
-
-